PTC Therapeutics, Inc. Property, Plant and Equipment, Gross
PTC Therapeutics, Inc. (PTCT) had Property, Plant and Equipment, Gross of $102.36 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-19
- 2025-12-31: Property, Plant and Equipment, Gross $102.36M.
- 2024-12-31: Property, Plant and Equipment, Gross $94.33M.
- 2023-12-31: Property, Plant and Equipment, Gross $138.36M.
- 2022-12-31: Property, Plant and Equipment, Gross $109.96M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $102.36M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $94.33M 10-K · filed 2026-02-19 | |
| 2023-12-31 | $138.36M 10-K · filed 2025-02-27 | |
| 2022-12-31 | $109.96M 10-K · filed 2024-02-29 | |
| 2021-12-31 | $79.76M 10-K · filed 2023-02-21 | |
| 2020-12-31 | $51.89M 10-K · filed 2022-02-22 | |
| 2019-12-31 | $33.37M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $20.18M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $41.22M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $38.36M 10-K · filed 2018-03-06 | |
| 2015-12-31 | $36.68M 10-K · filed 2017-03-16 | |
| 2014-12-31 | $34.08M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $29.41M 10-K · filed 2015-03-02 | $29.41M 10-K · filed 2014-03-06 |
| 2012-12-31 | $28.57M 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |